Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1−10000 nM) (physiological agonist at α and β-adrenoceptors), resulting in significantly increased Cx43-expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α-adrenergic agonist) or isoproterenol (β-adrenergic agonist) (0.1−1000 nM) for 24 h. Both catecholamines lead to a concentration-dependent increase in Cx43 protein and mRNA expression . Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole-cell voltage clamp demonstrated that increased Cx43-expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24-h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.
mammalian hearts several connexins are expressed: connexin 40 (Cx40), connexin 43 (Cx43), connexin 45 (Cx45) (1) . Among these Cx43 is found in cardiomyocytes of the ventricle, some parts of the conducting system, and the atria, whereas Cx40 is predominantly localized in the atria and in small amounts in the conduction system (2) . Cx45 is expressed in embryonic stages of the heart and also may be found in very small amounts in the Purkinje system of adult hearts. The gap junction channels formed by different connexins differ in their biophysical properties; i.e., regulation, permeability, and conductance. Cx43 has a short half-life time of ~90 min (3, 4) . Cx43, which is the most important connexin found in the working myocardium, is essential for normal ventricular function. Disturbances in Cx43 expression and distribution may lead to lifethreatening arrhythmias. Besides single-channel conductance and open probability, the number of channels regulates the macroscopic gap junction conductance. However, there is still little knowledge about physiological or pharmacological regulation of cardiac gap junction protein expression, in particular, with regard to concentration-response curves, which, on the other hand, are necessary to evaluate whether the effect may be relevant. It has been shown by Dupont et al. (5) that in patients suffering from congestive heart failure Cx43 content is down-regulated, in contrast to patients with compensated left ventricular hypertrophy showing an increase in Cx43 expression, as demonstrated by Peters et al. (6) and Kostin et al. (7) . Catecholamines play an important role in many cardiac diseases such as dilative cardiomyopathy. As early as 1984, Swedberg et al. (8) found elevated levels of norepinephrine in the blood of patients with chronic congestive heart failure compared with patients with normal left ventricular function. Moreover, a typical problem in these patients is the occurrence of ventricular arrhythmia. At present, nothing is known on the effects of an α-adrenergic stimulation on cardiac connexin expression. Moreover, although it has been shown in the classical paper by Darrow and colleagues (3) that a single (high) dose of dibutyryl-cAMP (1 mM) can up-regulate Cx43 within 24 h, nothing is known on the concentration-dependent effects of β-adrenergic stimulation. Thus, the goal of our study was to investigate whether subacute or chronic (24 h) stimulation of α-and β-adrenoceptors may alter Cx43 expression in ventricular cardiomyocytes (24 h stimulation would allow a several-fold turnover of proteins with half-life times of ~1-2 h-thus may be considered "chronic" or "subacute"-were chosen for this study). In addition, we wanted to assess concentration-response curves and determine EC 50 values in order to investigate whether such effects (if present) may occur in a physiologically or pharmacologically relevant concentration range, and, in addition, whether these effects depend on PKC or PKA, the protein kinases classically mediating α-or β-adrenergic effects. For the above purpose, we used a cell culture model of neonatal rat cardiomyocytes and analyzed Cx43 expression with Western blot and PCR technique and the well-established dual whole-cell voltage clamp method to asses the gap junction conductance and functional relevance of the findings. In addition, we performed in vivo experiments in adult rats to investigate whether the cell culture results also can be observed in the heart under in vivo conditions.
MATERIALS AND METHODS

Materials
Noradrenaline, phenylephrine, and isoproterenol were obtained from Sigma (Deisenhofen, Germany). H8 and BIM I were obtained from Alexis Biochemicals (San Diego, CA). Polyclonal rabbit anti-Cx43 antibody was bought from Sigma. Anti Cx40 antibody (polyclonal from rabbit) was purchased from Chemicon (Temecula, CA). Secondary antibody horseradish-labeled antibody, M199, and all other chemicals used were also obtained from Sigma (Deisenhofen, Germany). Monoclonal mouse anti-GAPDH antibody was obtained from HyTest (Finland). Fetal calf serum and collagenase II were purchased from Gibco Life Technologies (Karlsruhe, Germany). The primers were synthesized by BioTeZ GmbH Berlin, Germany.
Cell culture
Cardiomyocytes were isolated and cultured according to the following protocol (9): ventricles of new-born Wistar rats were digested in collagenase II solution, centrifuged, and, after a preplating period to remove noncardiac cells, resuspended in M199 medium containing 2 mM L-glutamine, 100 mg/ml streptomycin and penicillin, 1% fetal calf serum, and 10% horse serum (to inhibit fibroblast growth). The cells were seeded in petri dishes coated with 0.1% gelatin, and medium was changed three times a week. In a first set of experiments, confluent monolayers were exposed to noradrenaline (10 −10 -10 −5 M, each concentration with n=6) for 24 h and investigated for the expression of the cardiac connexins Cx43 and Cx40. Because noradrenaline can act on protein synthesis via both α1-and β-adrenoceptors, in a subsequent series of experiments, confluent monolayers were stimulated with either the α 1 -adrenoceptor agonist phenylephrine or the β-adrenoceptor agonist isoproterenol, both in concentrations ranging from 10 −6 to 10 −10 M (each concentration with n=5) for 24 h.
To elucidate the pathway of regulation in more detail, we performed additional experiments exposing the cells to either isoproterenol or phenylephrine (10 −6 to 10 −10 M) in the absence or presence of the protein kinase C (PKC) inhibitor bisindolylmaleimide I, used at a concentration of 5 µM 10 or the protein kinase A (PKA) inhibitor H8 (N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride) used at a concentration of 2µM 11 . Each of the inhibitors were administered concomitantly with either phenylephrine or isoproterenol for 24 h. Thereafter, connexin expression was analyzed using immunoblotting or PCR as described previously (9-11) and below.
Briefly, after 24 h treatment, cells were harvested and lysed using a low-salt buffer (K 2 HPO 4 20 mM pH=7.9, EDTA 1 mM, aprotinin 10 µg/ml, leupeptin 0.5 mg/ml, pepstatin A 7 µg/ml, Triton-X100 1%, PMSF 1 mM) for 4 h at 4°C. Total protein concentration was determined according to the method described by Lowry and colleagues. (12) Thereafter, 30-µg protein samples were diluted in 10-µl fivefold concentrated Laemmli buffer, and Western blot analysis of the Cx43, Cx40, or GAPDH content were carried out.
For investigation of Cx43 mRNA, cells were harvested using Trizol (Gibco, Karlsruhe, Germany), and cDNA was synthesized by reverse transcription using 1 µg total RNA. PCR was carried out with primer pairs for Cx43 or the housekeeping gene GAPDH (see below). The products of expected size (Cx43 600 bp and GAPDH 415 bp) were visualized in ethidium bromide-stained 1.5% agarose gels.
Western blots
The cell lysates were mixed with gel-loading buffer, according to Laemmli following classical protocols, and for electrophoresis, 30 µg protein per slot of each protein sample was fractionated through a 4% stacking and 10% running SDS-polyacrylamide gel (13) .
Proteins were then transferred electrically (semidry blot) on to a nitrocellulose membrane and blocked with 6% low-fat milk blocker at 4°C overnight. Primary antibody to Cx43 diluted 1:2000 or to Cx40 (diluted 1:100) were applied for 2 h at room temperature. Thereafter, the blots were washed 3 times with phosphate-buffered saline (PBS) containing in mM): 137 NaCl, 2.68 KCl, 8.1 Na 2 HPO 4 , 1.47 KH 2 PO 4 , and 0.1% Tween 20) and were incubated with secondary horseradish peroxidase-labeled antibody diluted 1:20,000 for 1 h at room temperature. Thereafter, connexins were detected using the iodophenol/luminol system by application of the ECL (enhanced chemiluminescence) Western blot detection kit from Amersham Pharmacia Biotech (Piscataway, NJ). Immunoblots were incubated in iodophenol/luminol reaction mixture (60 s) and exposed to X-ray film to detect chemiluminescence. The connexin bands were imaged on a scanner, and the pictures were digitized and analyzed with BioRad software (BioRad, München, Germany). After background, subtraction gray scale values of connexin signals in experimental preparations were compared with signals of the untreated control cells. Cx43 content was normalized to GAPDH content (assessed by the same method as described above). Protein transfer efficacy in Western blot was controlled by a standard probe. In the detected range of protein concentrations (Cx43, Cx40, and GAPDH), Western blot was linear using the above protocol.
Reverse transcription and PCR amplification
RNA was isolated using Trizol (Gibco BRL, Germany). Thereafter, RNA was reverse transcribed from 1 µg total RNA with random hexamer to generate fist-strand cDNA using standard protocols (14) . After first-strand cDNA was prepared, 1µl cDNA was mixed with PCR reagents to make a 25-µl solution containing 1U Taq DNA polymerase (Gibco, Germany), 10× PCR buffer, 1.5 mM MgCl 2 , 0.2 mM dNTP, and 0.5 µl of each primer. The amplification was carried out using the following primer according to Salameh et al. (15) : Cx43 antisense 5′-TTG TTT CTG TCA CCA GTA AC-3′, sense 5′-GAT GAG GAA GGA AGA GAA GC-3′, GAPDH antisense 5′-CCG CCT GCT TCA CCA CCT TCT-3′, sense 5′-GTC ATC ATC TCC GCC CCT TCC-3′. The cDNA amplification products of Cx43 were predicted to be 600 bp and of GAPDH 415 bp, respectively. The products were visualized and analyzed in ethidiumbromide-stained 1.5% agarose gels. Connexin expression was normalized to GAPDH expression.
Dual whole-cell voltage clamp
To assess gap junction conductance, vehicle-treated control cells, as well as cells treated with either isoproterenol 0.1 µM or phenylephrine 0.1 µM for 24 h were analyzed using the dual whole-cell voltage clamp method using the switch clamp technique. This technique for dual whole-cell voltage clamp assessment of gap junctional conductance has been described previously (16, 17) . Briefly, for the dual whole-cell voltage clamp. we used two switch clamp amplifiers (SEC 05, switching frequency 30 kHz; NPI Electronic, Tamm, Germany), which allow accurate measurement of gap junction conductance (g i ), independent of serial resistance (17) . Data were sampled at 1-10 kHz by using Eggworks software (NPI Electronic). For analysis, data were low-pass filtered at 1 kHz. Neonatal rat cardiomyocytes, after being subjected to 24 h treatment with either vehicle, 100 nM isoproterenol, or 100 nM phenylephrine were transferred to a 1-ml perfusion chamber mounted on the stage of an inverted microscope (Zeiss, Jena, Germany) and were superfused (1 ml/min) with Tyrode´s solution supplemented with 1 mM BaCl 2 Membrane resistance and capacitance were measured by a 200-ms voltage step from -40 to -50 mV. For the subsequent experiments, both cells were kept at a holding potential of -40 mV; thereafter, the potential of one cell was changed stepwise to potentials ranging from -90 to +10 mV in steps of 10 mV, 200 ms each, thus applying transjunctional voltage gradients ranging from -50 to +50 mV. The current elicited in the nonpulsed cell was taken as the gap junction current. The current-voltage relationships were always linear for ±50 mV, 200 ms transjunctional pulses, and g i was calculated as the slope by linear regression. Measurements were repeated every 60 s for a total period of 20 min.
In vivo experiments
All experiments were performed on female Sprague-Dawley rats (Charles River, Sulzfeld, Germany, n=18), weighing between 210 and 260 g. Animals used in this study were maintained in accordance with the Guide for Care and Use of Laboratory Animals published by the U.S. National Institute of Health (NIH Publication No. 85-23, revised 1996). The animals were allowed to move freely in their cages with access to tap water and rat chow diet (Altromin C 100, Altromin, Lage, Germany). All substances were given as constant intravenous infusion via a catheter (Vygon, Aachen, Germany) positioned in the left jugular vein (see Ref. 18) . The catheter was connected to a 20-ml syringe placed in an infusion pump (Infors, Basel, Switzerland; for details, see Ref. 18 ). The infusion rate was 4 ml/kg/h. Isoproterenol (n=6 rats) and phenylephrine (n=6 rats) were administered at a dose of 0.024 mg/kg/h and at 0.5 mg/kg/h, respectively, both being dissolved in 0.9% NaCl (concentrations adapted from previous work: (18) ). NaCl-infused animals (n=6 rats) served as controls. To prevent oxidation, 100 mg/l ascorbic acid was added to the solutions, and the syringes were protected from light. After 24 h infusion, hemodynamics in these rats was investigated using standard methods as described (19) . Thereafter, the hearts were rapidly excised, and ventricular tissue was analyzed for Cx43, Cx40, and GAPDH protein using Western blot as described above.
Statistical analysis
The concentration-response curves have been analyzed for C max , EC 50 , and Hill slope and were fitted to a sigmoidal curve using GraphPad Prism software (GraphPad Software, San Diego, CA 
RESULTS
Effects of 24 h adrenergic stimulation on cardiac connexin expression
Stimulation of cultured neonatal rat cardiomyocytes for 24 h with increasing concentrations of noradrenaline led to a concentration-dependent increase in Cx43 protein content with a log EC 50 of -9.08 ± 0.22 M, R 2 = 0.96 and a Hill slope of 1 without affecting Cx40 expression (Fig. 1A,  B) . GAPDH expression was not altered by the treatment. Because noradrenaline can stimulate protein synthesis via both, the α 1 -and the β-adrenoceptor, in subsequent experiments to evaluate the precise role of α 1 -and β-stimulation, we used for α-stimulation the selective α 1 -agonist phenylephrine and for β-stimulation the β-agonist isoproterenol. Both catecholamines when administered for 24 h provoked a significant and concentration-dependent increase in Cx43 protein content with a log EC 50 of −7.7 ± 0.19, R 2 = 0.97 for isoproterenol and −8.17 ± 0.14, R 2 = 0.99 for phenylephrine ( Fig. 2A, B) .
To determine whether this rise in Cx43 protein content is due to a regulation on the transcriptional level rather than due to a reduced Cx43 protein degradation, PCR studies were performed. In these experiments we found a significant increase (P<0.05) of Cx43 mRNA relative to the housekeeping gene GAPDH under the influence of a 24 h treatment with either 10 −7 M phenylephrine or 10 −7 M isoproterenol (Fig. 3A, B) . For further investigation of the underlying signal transduction pathway, we examined the influence of inhibitors of possibly relevant kinases on the phenylephrine or isoproterenol induced Cx43 up-regulation. For PKC inhibition BIM I was used, for PKA inhibition H8. The inhibitors were applied concomitantly to either isoproterenol or phenylephrine. The isoproterenol-induced Cx43 expression could be significantly antagonized by H8 but not by BIM I, while the phenylephrine-induced Cx43 expression was significantly inhibited by BIM I, but not by H8 (Fig. 4) .
Adrenergic stimulation increased the gap junction mediated intercellular communication between the cultured cardiomyocytes
The next question was, whether the up-regulation of Cx43 by α 1 -adrenoceptor stimulation or by β-adrenoceptor stimulation might indeed result in an enhanced electrical intercellular coupling. This question was addressed in dual whole-cell voltage-clamp experiments. Macroscopic gap junction currents determined in the dual whole-cell voltage-clamp mode ranged from 25 nS to 32 nS in pairs of neonatal ventricular cardiomyocytes under control conditions in a good accordance with the values reported in the literature (20, 21) . The mean junctional conductance between untreated neonatal rat cardiomyocytes was 29±4 nS (n=8). After 24 h treatment of the cardiomyocyte cultures with 100 nM of either phenylephrine or isoproterenol, a significant increase of electrical coupling up to 43 ± 4 nS (n=8) and 57 ± 8 nS (n=8), respectively, was detected between the cells (Fig. 5A) . Representative gap junction current traces are shown in Fig.  5B . Seal resistance in all cells was between 3 and 5 GΩ. Membrane resistance of these cells was 525 ± 34 MΩ, and membrane capacitance was 24 ± 2 pF.
h adrenergic stimulation up-regulates Cx43 but not Cx40 under in vivo conditions
The next part of our investigation was the examination of the effects of a 24 h α 1 -adrenoceptor stimulation or β-adrenoceptor stimulation by 24-h infusion of either phenylephrine or isoproterenol. The body weight of the rats was not different between the groups and was 247 ± 2 g for all rats. Left ventricular weight was 635 ± 17 mg for all with small, not significant differences between the groups (vehicle-treated control group: 570±32 mg; isoproterenol: 682±20 mg; phenylephrine: 630±23 mg) and slightly (but not significantly) increased left ventricular mass/body weight ratios (Table 1) . Both treatments exhibited functional responses in the treated animals demonstrating that the doses applied were in an effective range (see Table 1 ). Left ventricular pressure was significantly enhanced by isoproterenol as was dP/dt max , heart rate, cardiac output, and cardiac index. Phenylephrine resulted in a mild positive inotropic response, as can be seen from a small increase in dP/dt max , while heart rate and cardiac index were not significantly altered (Table 1) . However, regarding the cardiac connexins, we found, in good agreement with the cell culture results, a significant up-regulation of Cx43 by both isoproterenol and phenylephrine, while Cx40 again remained unchanged (Fig. 6A, B) .
DISCUSSION
In previous investigations, several authors have shown that acute activation of the adenylyl cyclase/cAMP/PKA pathway or activation of the PKC can regulate connexin phosphorylation, assembly, or expression, thereby altering cell coupling and communication (3 9, 22-25) . Others could demonstrate that chronic adrenergic stimulation can induce hypertrophic responses in cardiomyocytes mainly via α-adrenoceptor stimulation (26, 27) . However, until now, it remained unclear whether the expression of cardiac connexins can also be regulated by α-or β-adrenoceptor stimulation, whether this is of functional importance, and whether the finding of an increased Cx43 expression in neonatal rat cardiomyocytes following dibutyryl-cAMP can also be achieved by β-adrenoceptor stimulation and whether these findings can be transferred to the in vivo situation (3, 28) . The data of our study now show, that 24-h α-or β-adrenergic stimulation both in vitro and in vivo lead to an up-regulation of Cx43 but not Cx40.
Noradrenaline can activate both α-and β-adrenoceptors and plays a predominant role as a physiological mediator in many cardiac diseases. A role for sympathetic regulation of cardiac connexin expression has, to our best knowledge, not been described so far. First, our data show that noradrenaline can lead to a differential regulation of the cardiac connexins with enhanced Cx43 expression and unaffected Cx40 expression. The EC 50 of ~1 nM supports the view of a specific catecholamine effect (29, 30) , but, because noradrenaline acts on both α-and β-adrenoceptors, it does not allow us to conclude which adrenoceptor subtype is involved.
The investigations using α-and β-adrenoceptor-specific stimulators revealed that both α-and β-adrenoceptor activation lead to selective up-regulation of Cx43 on protein and mRNA level. Thus, phenylephrine leads to an increase in Cx43 protein with a pEC 50 of 8.17, which is compatible with a specific action on α-adrenoceptors (29, 30) . It has been shown by others that the α 1 -adrenoceptor is involved in hypertrophic responses in cardiomyocytes acting via a G q -PKC signal transduction cascade (31) (32) (33) . Thus, our finding that phenylephrine-induced Cx43 expression could be suppressed by bisindolylmaleimide I fits with the hypothesis of an α-adrenoceptor-PKC signal transduction in good accordance with others. Moreover, it was shown in uterine muscle that Cx43 can be induced by stimulation of PKC (34) . It is known that the α 1 -adrenoceptor is coupled to PKC via a G q/11 protein. Interestingly, it was previously shown that other G q/11 -coupled receptors, namely AT 1 and ET A receptors, also induce Cx43 expression (but not Cx40) (9, 35) . The work of Schlüter and coworkers as that of Brodde and colleagues (26, 27, 31, 32, 33, 36) shows the involvement of α-adrenoceptors in hypertrophic responses of the heart. In that respect, the finding of an enhanced expression of Cx43 after α-adrenoceptor stimulation by phenylephrine would be in line with the findings of Kostin and coworkers (7) of increased Cx43 protein expression in patients with compensated left ventricular hypertrophy due to aortic stenosis (with ejection fraction: >50% and dP: >60 mmHg). In later stages with manifest heart failure (ejection fraction: <30%), Cx43 is decreased, as was also reported for dilated cardiomyopathy or ischemic cardiomyopathy (6, 37) . Thus, an up-regulation of Cx43 levels might be typical for hypertrophic cardiac responses, as it was also seen in left ventricular tissue from guinea pigs with renovascular hypertension and secondary cardiac hypertrophy (38) . Our in vivo data show that the finding of phenylephrine-induced enhancement of Cx43 expression can indeed be transferred to the in vivo situation.
Similarly, we found that isoproterenol also induced Cx43 expression on protein and mRNA level with a pEC 50 of 7.7 for the Cx43 protein, which is compatible with a specific action on β-adrenoceptors (39, 40) . The further investigation revealed that this isoproterenol effect could be significantly suppressed by H8, indicating involvement of cAMP-dependent protein kinase A. This is in good agreement with previous results of our group and others showing that incubation of neonatal rat cardiomyocytes with dibutyryl-cAMP also leads to up-regulation of Cx43 (3, 28) . Moreover, we also found that direct stimulation of adenylylcyclase by forskolin also results in enhanced expression of Cx43 in these cells (28) . Thus, these results together with the literature indicate that-at least in rat cardiomyocytes-Cx43 expression can be regulated via the β-adrenoceptor/adenylylcyclase/cAMP/PKA signal transduction pathway. Obviously, the upregulation of Cx43 by β-adrenoceptor stimulation was also functionally relevant, as can be seen from the enhanced macroscopic gap junction conductance. The finding that besides Cx43 protein Cx43 mRNA was increased under adrenergic stimulation is in favor of the assumption of either enhanced de novo synthesis or alternatively of stabilization of Cx43 mRNA.
Regarding the functional relevance, our data show that the increased expression of Cx43 following both α-and β-adrenoceptor stimulation was indeed associated with enhanced gap junctional intercellular communication. Thus, we conclude that at least a portion of the increased Cx43 seems to form functional channels. This also means, that the degree of gap junctional intercellular communication can be regulated by enhanced synthesis of connexins, in this special case Cx43, in response to either α-or β-adrenergic stimulation. This might lead to an interesting new principle of regulating the biophysical properties and opens new therapeutic approaches (or new explanations for drug effects).
The effective concentrations of noradrenaline, isoproterenol, or phenylephrine experimentally determined in the cell culture of neonatal rat ventricular cardiomyocytes were around ~1-20 nM. This concentration range, in the case of noradrenaline, could be comparable to that detected in cardiac tissue (41) . The two-to threefold increase in the Cx43 expression level observed in the cardiomyocytes could result in changes in electrical coupling between the cells that may affect the heart tissue physiology. Indeed, the cardiomyocytes cultures after 24 h exposure to either catecholamine demonstrated about twofold increase in the electrical coupling between the cells. This finding of a functional importance of catecholamines for the electrical impulse propagation between the heart muscle cells may have clinical relevance and help improve therapy for heart disease.
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The up-regulation, which we found occurred within 24 h. On the background of a half-life time of only 90 min for Cx43 (3, 4) , it is reasonable that changes in expression of this membrane protein take place within a time window of 24 h, which may indicate that cardiomyocytes may adapt their communication permanently to the current situation.
A next point to consider is the in vivo relevance. Although neonatal rat cardiomyocytes are a well-established model for investigation of gap junction expression, one might argue that in adult cells, this regulation could be different. However, it is impossible to study this effect in adult cardiomyocytes since these are postmitotic cells, which, after isolation, decrease their Cx43 expression, and several days after isolation in culture, they change their morphology to a more embryonic type (so-called cardioballs) and then again increase Cx43 expression, so that in adult cells, there are no stable conditions (42) . To circumvent this point, we decided to infuse catecholamines in vivo in adult rats and investigate Cx expression after 24-h constant infusion. These results confirmed our in vitro findings and also revealed clear Cx43 up-regulation following α-or β-adrenoceptor stimulation without affecting Cx40 expression. In addition, the similarity of the in vitro and in vivo findings supports the use of neonatal rat cardiomyocytes as a model for cardiac connexin expression regulation.
However, although isoproterenol and phenylephrine are pharmacological tools, the physiological mediator released from nerve terminals is noradrenaline, which stimulates both α-and β-adrenoceptors. In the rat, there are considerably more α 1 -adrenoceptors than in other species (about fivefold) (43) , while in the human heart, there is only a small number of α 1 -adrenoceptors as compared with β 1 -adrenoceptors (44, 45) , so that the total effect of noradrenaline on Cx43 expression in our rat models may resemble more α 1 -adrenergic action than in other species. However, the effects of isoproterenol clearly show that there is a significant up-regulation of Cx43 after β-adrenoceptor stimulation, which is the predominant adrenergic receptor in most mammalian species. This is to our best knowledge the first description of a subacute (24 h) concentration-dependent differential regulation of cardiac connexins by catecholamine-induced stimulation of α-or β-adrenergic receptors in both in vitro and in vivo models.
Pathophysiologically, noradrenaline release is enhanced in many cardiac diseases and has been shown to be involved in cardiac hypertrophy, which often is also associated with arrhythmia. An up-regulation of Cx43 with altered intercellular coupling (as shown in our study) might contribute to the formation of an arrhythmogenic substrate. We assume that this might play a role in subacute or hypertrophic responses of the ventricles to adrenergic stimulation, in good agreement with the clinical findings of Kostin et al. (7), demonstrating increased Cx43 protein expression in patients with compensated left ventricular hypertrophy due to aortic stenosis. Besides hypertrophy, the findings of our paper may also relate to the situation in patients suffering from early stages of heart failure (ejection fraction 50-55%, stage: NYHA II), in which β1-adrenoceptors are still functional, although already confronted with enhanced local catecholamine levels. These patients are at high risk for ventricular fibrillation, and treatment with β-adrenoceptor antagonists such as metoprolol has been shown to reduce mortality. It might be speculated that there may be a link between our findings of β-adrenoceptor-mediated increases in Cx43 expression, the risk of ventricular fibrillation, and the therapeutic success of β-blockers in these patients. However, to understand this, it is necessary to keep in mind the importance of not only the expression level of connexins, but also the localization of the functional gap junction channels with regard to the cell axis to the regular propagation of the cardiac electrical impulse. Our findings cannot be generalized to late stages with manifest heart failure (ejection fraction: <30%), when Cx43 is decreased (6, 37, 38) . However, because in these later stages, β-adrenoceptors are down-regulated and the responsiveness of the β-adrenoceptor adenylylcyclase system is decreased, our findings would predict a reduction in Cx43 expression, as has been indeed described by several groups (5-7, 37, 38) . This may also lead to conduction failure and arrhythmia, especially if, locally, Cx43 is decreased by more than 50% and inhomogeneity is increased, which also was observed (5-7, 37, 38), but might not be found in all patients. 
